[1]
|
Liao, C.I., Chow, S., Chen, L.M., Kapp, D.S., Mann, A., and Chan, J.K. (2018) Trends in the Incidence of Serous Fallopian Tube, Ovarian, and Peritoneal Cancer in the US. Gynecologic Oncology, 149, 318-323.
https://doi.org/10.1016/j.ygyno.2018.01.030
|
[2]
|
Piek, J.M., van Diest, P.J., Zweemer, R.P., Jansen, J.W., Poort-Keesom, R.J., Menko, F.H., Gille, J.J., Jongsma, A.P., Pals, G., Kenemans, P. and Verheijen, R.H. (2001) Dysplastic Changes in Prophylactically Removed Fallopian Tubes of Women Predisposed to Developing Ovarian Cancer. The Journal of Pathology, 195, 451-456.
https://doi.org/10.1002/path.1000
|
[3]
|
Kindelberger, D.W., Lee, Y., Miron, A., Hirsch, M.S., Feltmate, C., Medeiros, F., Callahan, M.J., Garner, E.O., Gordon, R.W., Birch, C., Berkowitz, R.S., Muto, M.G. and Crum, C.P. (2007) Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship. The American Journal of Surgical Pathology, 31, 161-169. https://doi.org/10.1097/01.pas.0000213335.40358.47
|
[4]
|
Ottevanger, P.B. (2017) Ovarian Cancer Stem Cells More Questions than Answers. Seminars in Cancer Biology, 44, 67-71.
https://doi.org/10.1016/j.semcancer.2017.04.009
|
[5]
|
Crum, C.P., Herfs, M., Ning, G., Bijron, J.G., Howitt, B.E., Jimenez, C.A., Hanamornroongruang, S., McKeon, F.D. and Xian, W. (2013) Through the Glass Darkly: Intraepithelial Neoplasia, Top-Down Differentiation, and the Road to Ovarian Cancer. The Journal of Pathology, 231, 402-412. https://doi.org/10.1002/path.4263
|
[6]
|
Jarboe, E., Folkins, A., Nucci, M.R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y. and Crum, C.P. (2008) Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification. International Journal of Gynecological Pathology, 27, 1-9.
https://doi.org/10.1097/pgp.0b013e31814b191f
|
[7]
|
Kurman, R.J. and Shih Ie, M. (2010) The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. The American Journal of Surgical Pathology, 34, 433-443. https://doi.org/10.1097/PAS.0b013e3181cf3d79
|
[8]
|
Visvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., Shih Ie, M. and Kurman, R.J. (2011) Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features: A Reproducibility Study. The American Journal of Surgical Pathology, 35, 1766-1775.
https://doi.org/10.1097/PAS.0b013e31822f58bc
|
[9]
|
Meyer, L.A., Anderson, M.E., Lacour, R.A., Suri, A., Daniels, M.S., Urbauer, D.L., Nogueras-Gonzalez, G.M., Schmeler, K.M., Gershenson, D.M. and Lu, K.H. (2010) Evaluating Women with Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed Opportunities. Gynecologic Oncology, 115, 945-952.
https://doi.org/10.1097/AOG.0b013e3181da08d7
|
[10]
|
Palma, M., Ristori, E., Ricevuto, E., Giannini, G. and Gulino, A. (2006) BRCA1 and BRCA2: The Genetic Testing and the Current Management Options for Mutation Carriers. Critical Reviews in Oncology/Hematology, 57, 1-23.
https://doi.org/10.1016/j.critrevonc.2005.05.003
|
[11]
|
Patrono, M.G., Iniesta, M.D., Malpica, A., Lu, K.H., Fernandez, R.O., Salvo, G. and Ramirez, P.T. (2015) Clinical Outcomes in Patients with Isolated Serous Tubal Intraepithelial Carcinoma (STIC): A Comprehensive Review. Gynecologic Oncology, 139, 568-572. https://doi.org/10.1016/j.ygyno.2015.09.018
|
[12]
|
Zakhour, M., Danovitch, Y., Lester, J., Rimel, B.J., Walsh, C.S., Li, A.J., Karlan, B.Y. and Cass, I. (2016) Occult and Subsequent Cancer Incidence Following Risk-Reducing Surgery in BRCA Mutation Carriers. Gynecologic Oncology, 143, 231-235. https://doi.org/10.1016/j.ygyno.2016.08.336
|
[13]
|
Chen, H., Klein, R., Arnold, S., Chambers, S. and Zheng, W. (2016) Cytologic Studies of the Fallopian Tube in Patients Undergoing Salpingo-Oophorectomy. Cancer Cell International, 16, 78. https://doi.org/10.1186/s12935-016-0354-x
|
[14]
|
Mehra, K., Mehrad, M., Ning, G., Drapkin, R., McKeon, F.D., Xian, W. and Crum, C.P. (2011) STICS, SCOUTs and p53 Signatures; A New Language for Pelvic Serous Carcinogenesis. Frontiers in Bioscience (Elite Edition), 3, 625-634.
|
[15]
|
Malmberg, K., Klynning, C., Floter-Radestad, A. and Carlson, J.W. (2016) Serous Tubal Intraepithelial Carcinoma, Chronic Fallopian Tube Injury, and Serous Carcinoma Development. Virchows Arch, 468, 707-713.
https://doi.org/10.1007/s00428-016-1928-7
|
[16]
|
Salvador, S., Gilks, B., Kobel, M., Huntsman, D., Rosen, B. and Miller, D. (2009) The Fallopian Tube: Primary Site of Most Pelvic High-Grade Serous Carcinomas. International Journal of Gynecological Cancer, 19, 58-64.
https://doi.org/10.1111/IGC.0b013e318199009c
|
[17]
|
Takeshita, R., Shoji, T., Mukaida, R., Sato, T., Sasou, S., Itamochi, H. and Sugiyama, T. (2017) A Case of High-Grade Serous Tubal Intraepithelial Carcinoma Diagnosed with Adenocarcinoma by Ascitic Fluid Cytology. Journal of Tumor, 5, 488-491.
|
[18]
|
Bamias, A., Papadimitriou, C., Efstathiou, E., Rodolakis, A., Vlahos, G., Voulgaris, Z., Bozas, G., Fountzilas, G., Aravantinos, G., Razis, E., Gika, D. and Dimopoulos, M.A. (2006) Four Cycles of Paclitaxel and Carboplatin as Adjuvant Treatment in Early-Stage Ovarian Cancer: A Six-Year Experience of the Hellenic Cooperative Oncology Group. BMC Cancer, 6, 228.
|
[19]
|
Weinberger, V., Bednarikova, M., Cibula, D. and Zikan, M. (2016) Serous Tubal Intraepithelial Carcinoma (STIC)—Clinical Impact and Management. Expert Review of Anticancer Therapy, 16, 1311-1321.
https://doi.org/10.1080/14737140.2016.1247699
|
[20]
|
Tone, A.A., Virtanen, C., Shaw, P. and Brown, T.J. (2012) Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis. Clinical Cancer Research, 18, 4334-4344.
https://doi.org/10.1158/1078-0432.CCR-12-0199
|
[21]
|
Crum, C.P., Parkash, V., Alvarado-Cabrero, I., Piek, J.M.J., Bijron, J.G., Shaw, P., Carcangiu, M.L., Soslow, R., Ferry, J.A., van Diest, P.J. and Vang, R. (2014) Epithelial Tumours and Cysts. In: Kurman, R.J., Carcangiu, M.L., Herrington, C.S. and Young, R.H., Eds., WHO Classification of Tumours of Female Reproductive Organs, International Agency for Research on Cancer (IARC), Lyon, 103-112.
|
[22]
|
Sasagawa, M., Nishino, K., Honma, S., Kodama, S. and Takahashi, T. (2003) Origin of Adenocarcinoma Cells Observed on Cervical Cytology. Acta Cytologica, 47, 410-414. https://doi.org/10.1159/000326542
|
[23]
|
Hong, M.K., Lee, M.H., Ding, D.C., Chu, S.C. and Chu, T.Y. (2015) High Grade Serous Ovarian Carcinoma with Serous Tubal Intraepithelial Carcinoma in a Case Presented with Atypical Glandular Cell Favor Neoplasm Cervical Cytology and Dermatomyositis. Taiwanese Journal of Obstetrics & Gynecology, 54, 183-186.
https://doi.org/10.1016/j.tjog.2013.07.004
|
[24]
|
Punnonen, R., Lauslahti, K. and Pystynen, P. (1985) Primary Malignancies of the Fallopian Tube. Annales Chirurgiae et Gynaecologiae. Supplementum, 197, 15-18.
|
[25]
|
Maeda, D., Takazawa, Y., Ota, S., Takeuchi, Y., Seta, A., Nakagawa, S., Yano, T., Taketani, Y. and Fukayama, M. (2010) Bilateral Microscopic Adenocarcinoma of the Fallopian Tubes Detected by an Endometrial Cytologic Smear. International Journal of Gynecological Pathology, 29, 273-277.
https://doi.org/10.1097/PGP.0b013e3181c30301
|
[26]
|
Manchanda, R., Drapkin, R., Jacobs, I. and Menon, U. (2012) The Role of Peritoneal Cytology at Risk-Reducing Salpingo-Oophorectomy (RRSO) in Women at Increased Risk of Familial Ovarian/Tubal Cancer. Gynecologic Oncology, 124, 185-191. https://doi.org/10.1016/j.ygyno.2011.10.017
|
[27]
|
Takahashi, M., Kigawa, J., Ishihara, K., Shimada, M., Kamei, T. and Terakawa, N. (2002) Hydrotubation for Diagnosing Carcinoma in Situ of the Fallopian Tube. A Case Report. Acta Cytologica, 46, 735-737. https://doi.org/10.1159/000326986
|